Cord Blood America (CBAI) stock price, revenue, and financials

Cord Blood America market cap is $9.9 m.
View Company

$9.9 M

CBAI Mkt cap, 02-Jul-2020
Cord Blood America Net income (Q1, 2020)-122.7 K
Cord Blood America EBIT (Q1, 2020)-184.9 K
Cord Blood America Cash, 31-Mar-202011.5 M

Cord Blood America Income Statement

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

5.7m6.0m6.0m4.3m5.3m3.3m

Revenue growth, %

(28%)21%(37%)

Cost of goods sold

1.9m1.8m2.0m1.4m1.9m904.9k

Gross profit

3.8m4.2m4.0m3.0m3.4m2.4m

Gross profit Margin, %

67%70%66%68%65%72%

General and administrative expense

7.6m5.6m

Operating expense total

7.8m5.4m5.1m3.1m3.0m2.5m1.7m3.9m

EBIT

(3.9m)(1.2m)(1.1m)(168.9k)385.5k(106.3k)(1.7m)(3.9m)(639.4k)

EBIT margin, %

(69%)(21%)(19%)(4%)7%(3%)

Interest expense

80.8k2.1k

Pre tax profit

(6.5m)2.4m(3.0m)240.1k437.9k102.2k(1.6m)(3.8m)(403.0k)

Income tax expense

(61.8k)(714.6k)(86.2k)

Net Income

(6.0m)(1.1m)(3.0m)240.1k437.9k102.2k407.4k13.2m(36.8k)

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Revenue

1.4m1.5m1.6m1.8m1.5m1.5m1.5m1.5m1.4m1.5m1.2m1.3m1.4m1.4m986.3k793.2k775.0k745.9k746.4k747.7k

Cost of goods sold

459.8k436.8k434.8k518.0k422.5k440.0k474.1k474.9k439.2k473.3k423.1k402.5k508.7k545.5k340.3k201.5k172.9k170.9k176.0k162.2k

Gross profit

970.6k1.1m1.1m1.3m1.1m1.0m1.0m1.0m976.3k1.1m774.2k875.6k904.3k885.0k646.0k591.8k602.1k575.0k570.4k585.5k

Gross profit Margin, %

68%71%72%71%72%70%68%68%69%69%65%69%64%62%65%75%78%77%76%78%

General and administrative expense

1.9m1.6m1.4m1.4m1.1m1.1m1.2m

Operating expense total

1.9m1.6m1.4m1.2m1.1m1.1m1.2m1.3m1.3m1.3m754.1k773.6k871.9k658.6k665.4k600.7k497.9k501.5k441.6k414.8k428.9k762.7k297.4k103.4k148.6k197.6k

EBIT

(906.1k)(494.4k)(264.6k)93.5k(33.0k)(94.9k)(156.7k)(253.0k)(346.2k)(245.1k)20.1k102.0k32.4k226.4k(19.3k)(8.9k)104.2k73.5k128.7k170.7k(428.9k)(762.7k)(297.4k)(103.4k)(148.6k)(197.6k)(184.9k)

EBIT margin, %

(63%)(33%)(17%)5%(2%)(7%)(11%)(17%)(24%)(16%)2%8%2%16%(2%)(1%)13%10%17%23%

Interest expense

Pre tax profit

(1.1m)(1.0m)(1.3m)159.0k(103.8k)(587.9k)(507.3k)(591.7k)(545.5k)(926.7k)538.7k(208.7k)69.3k208.4k(7.6k)(31.8k)139.5k121.7k150.0k177.3k(422.1k)(756.3k)(263.9k)(55.3k)(51.1k)(154.4k)(155.3k)

Income tax expense

(260.0k)(8.3k)(12.9k)(8.9k)(28.1k)(32.6k)

Net Income

(1.0m)(979.5k)(1.3m)148.1k(917.7k)(587.9k)(507.3k)(591.7k)(545.5k)(927.7k)1.5m(208.7k)396.9k228.3k(7.6k)(31.8k)139.5k121.7k150.0k177.3k36.6k13.8m(93.5k)(42.5k)(42.2k)(126.3k)(122.7k)

Cord Blood America Balance Sheet

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

196.4k393.8k708.8k750.9k789.0k926.2k1.1m12.4m11.5m

Accounts Receivable

213.4k181.7k155.7k287.6k349.9k61.7k11.9k33.8k

Prepaid Expenses

91.8k91.9k410.3k79.7k151.9k146.5k113.3k96.1k

Inventories

58.4k

Current Assets

832.0k1.0m1.7m1.2m1.5m1.3m2.4m12.5m11.7m

PP&E

734.7k801.6k653.8k127.0k119.2k9.1k

Goodwill

244.1k244.1k244.1k

Total Assets

7.4m6.4m6.1m3.9m3.7m3.1m2.9m15.6m14.8m

Accounts Payable

1.2m538.3k592.8k363.1k152.8k151.3k371.2k109.7k37.3k

Short-term debt

789.9k1.1m5.3m4.1m4.3m

Current Liabilities

5.7m4.5m6.1m2.6m2.3m2.3m1.9m1.4m655.6k

Long-term debt

1.5m653.8k899.3k409.5k

Total Debt

2.3m1.7m5.3m5.0m4.7m

Total Liabilities

8.2m5.8m6.4m4.6m3.2m2.6m1.9m1.4m655.6k

Common Stock

636.0k659.7k89.0k89.0k127.2k127.2k127.2k127.2k

Preferred Stock

Additional Paid-in Capital

47.7m50.9m53.3m53.3m54.0m54.0m54.0m54.0m54.0m

Retained Earnings

(48.8m)(51.2m)(53.7m)(53.4m)(53.0m)(52.9m)(52.5m)(39.3m)(39.4m)

Total Equity

(878.8k)516.4k(370.3k)(691.2k)474.4k576.7k984.1k14.2m14.1m

Debt to Equity Ratio

-2.6 x3.4 x-14.3 x-7.3 x10 x

Debt to Assets Ratio

0.3 x0.3 x0.9 x1.3 x1.3 x

Financial Leverage

-8.4 x12.3 x-16.4 x-5.6 x7.8 x5.4 x2.9 x1.1 x1 x

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Cash

206.1k235.5k300.6k332.9k369.2k393.6k613.0k595.3k802.5k701.9k699.4k644.2k708.1k776.8k1.0m1.2m1.1m821.4k733.1k959.5k1.2m13.2m12.0m11.9m11.5m11.4m11.5m

Accounts Receivable

446.1k387.8k234.6k261.5k237.3k220.0k245.7k209.3k214.5k268.9k323.3k384.8k500.8k532.7k213.8k135.5k121.7k48.7k22.0k42.3k66.8k223.4k271.0k8.8k21.6k36.1k26.3k

Prepaid Expenses

164.5k114.4k119.5k239.7k129.8k146.0k120.0k371.0k164.0k324.0k71.0k74.9k66.8k86.7k108.8k77.5k39.3k124.1k102.6k62.3k108.0k74.3k26.5k107.6k106.6k101.4k77.2k

Inventories

105.8k

Current Assets

952.9k1.1m931.3k1.1m1.1m1.1m1.4m1.6m1.5m1.6m1.2m1.3m1.5m1.6m1.5m1.6m1.4m1.1m945.7k1.2m2.5m13.6m12.7m12.0m11.6m11.5m11.6m

PP&E

636.9k669.1k758.5k812.2k704.8k876.1k809.4k747.3k641.8k612.5k139.0k125.9k115.7k107.1k106.7k94.4k82.3k60.4k54.5k49.1k7.7k6.4k5.1k

Goodwill

244.1k244.1k244.1k244.1k244.1k244.1k244.1k244.1k244.1k244.1k

Total Assets

7.6m7.6m7.4m7.4m7.3m6.4m6.4m5.8m5.6m4.0m3.8m3.9m3.9m3.6m3.5m3.3m2.8m2.6m2.7m2.9m17.0m15.8m15.0m14.7m14.5m14.7m

Accounts Payable

1.1m953.9k950.2k1.0m607.7k583.9k489.2k515.5k523.3k591.0k457.5k407.5k295.6k211.0k109.7k40.8k7.9k116.3k97.1k110.0k358.3k235.1k67.4k8.2k301.050.6k79.1k

Short-term debt

1.4m740.2k305.3k866.5k263.6k1.1m1.1m4.9m5.5m5.6m5.1m4.3m4.1m3.9m4.6m4.8m4.8m4.4m4.4m4.4m

Current Liabilities

6.3m5.0m5.0m5.2m3.7m4.5m4.7m5.6m6.1m6.9m4.3m3.3m2.2m2.1m2.5m2.6m2.5m1.9m1.5m1.4m1.9m2.1m1.1m928.9k591.8k597.9k697.4k

Long-term debt

1.7m1.6m1.2m800.2k1.5m479.4k310.0k220.4k556.1k683.5k596.8k208.2k157.6k

Total Debt

3.1m2.4m1.5m1.7m1.8m1.5m1.4m5.1m5.5m5.6m5.1m4.8m4.8m4.5m4.8m4.9m4.8m4.4m4.4m4.4m

Total Liabilities

8.0m7.0m7.3m6.8m6.0m5.8m5.9m6.3m6.4m7.2m4.7m4.7m3.7m3.4m3.2m3.1m2.7m2.1m1.8m1.7m1.9m2.1m1.1m928.9k591.8k597.9k697.4k

Common Stock

711.6k1.0m647.1k647.1k647.1k686.9k701.1k711.1k89.0k89.0k89.0k89.0k127.2k127.2k127.2k127.2k127.2k127.2k127.2k127.2k127.2k127.2k127.2k127.2k127.2k127.2k127.2k

Preferred Stock

Additional Paid-in Capital

44.6m46.3m50.0m50.4m50.4m51.5m51.8m52.0m53.3m53.3m53.3m53.3m54.0m54.0m54.0m54.0m54.0m54.0m54.0m54.0m54.0m54.0m54.0m54.0m54.0m54.0m54.0m

Retained Earnings

(45.6m)(46.6m)(50.0m)(49.9m)(50.0m)(51.8m)(52.2m)(52.6m)(54.1m)(55.0m)(53.5m)(53.7m)(53.3m)(53.0m)(53.0m)(53.0m)(52.9m)(52.8m)(52.6m)(52.5m)(52.5m)(38.7m)(38.8m)(39.4m)(39.4m)(39.5m)(39.5m)

Total Equity

(441.5k)552.6k101.0k682.1k1.3m606.6k487.7k140.2k(682.2k)(1.6m)(708.4k)(900.0k)224.7k453.1k466.8k435.0k574.6k698.4k848.4k1.0m1.0m14.8m14.7m14.1m14.1m13.9m14.0m

Debt to Equity Ratio

-7.1 x4.3 x14.9 x2.4 x1.4 x2.5 x2.9 x36.4 x-8.1 x-3.5 x-7.2 x-5.4 x21.2 x9.8 x10.4 x11.4 x8.4 x6.3 x5.2 x4.3 x

Debt to Assets Ratio

0.4 x0.3 x0.2 x0.2 x0.2 x0.2 x0.8 x1 x1 x1.3 x1.3 x1.2 x1.2 x1.3 x1.4 x1.5 x1.6 x1.7 x1.6 x

Financial Leverage

-17.1 x13.7 x73.4 x10.9 x5.6 x10.5 x45.7 x-8.4 x-3.5 x-5.6 x-4.2 x17.2 x8.6 x7.8 x8.1 x5.8 x4.1 x3.1 x2.6 x2.8 x1.1 x1.1 x1.1 x1 x1 x1 x

Cord Blood America Cash Flow

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Net Income

(6.0m)(1.1m)(3.0m)240.1k437.9k102.2k(3.1m)(36.8k)

Depreciation and Amortization

790.2k792.7k787.3k474.5k399.9k363.2k5.4k9.1k

Accounts Receivable

(197.2k)(177.3k)(106.6k)196.5k38.3k39.6k(22.0k)

Inventories

(66.6k)(18.5k)(45.4k)

Accounts Payable

116.5k23.9k16.0k(1.5k)219.9k(261.5k)(72.4k)

Cash From Operating Activities

(1.9m)190.3k496.1k779.6k734.0k577.4k(1.9m)(4.8m)(880.3k)

Purchases of PP&E

(314.5k)(309.4k)(142.6k)(45.6k)(46.7k)

Capital Expenditures

20.0k

Cash From Investing Activities

(946.7k)(403.3k)(142.6k)(120.6k)5.1k134.8k55.0k350.0k

Short-term Borrowings

1.1m(100.0k)(1.4m)(575.0k)(300.0k)

Cash From Financing Activities

2.7m427.3k(100.0k)(701.0k)(575.0k)(300.0k)

Net Change in Cash

(150.9k)212.3k314.9k42.1k38.2k137.2k143.7k14.3m(880.3k)

Interest Paid

80.8k2.1k214.1k

Income Taxes Paid

Free Cash Flow

557.4k(1.9m)

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Net Income

(2.8m)(3.8m)(1.3m)(1.1m)(1.1m)(587.9k)(1.1m)(1.7m)(545.5k)(1.5m)222.9k(208.7k)188.2k416.6k(7.6k)(39.4k)100.1k121.7k271.7k449.0k(1.4m)(42.5k)(84.7k)(210.9k)(122.7k)

Depreciation and Amortization

384.6k578.8k204.2k400.8k595.2k193.4k385.8k577.8k181.1k364.3k402.3k106.0k204.4k303.2k97.4k186.9k275.7k82.8k157.7k231.5k1.3k2.7k4.0k

Accounts Receivable

(190.2k)(254.8k)(213.0k)(112.1k)(262.5k)(280.5k)128.9k202.7k211.0k26.4k44.1k14.9k(14.5k)(177.9k)(225.5k)3.1k(9.8k)(24.3k)7.5k

Inventories

(52.2k)(18.5k)12.9k1.3k5.8k12.7k(4.0k)(2.0k)(1.0k)

Accounts Payable

81.6k45.9k118.4k44.4k(67.4k)(152.1k)(43.1k)(112.0k)(144.9k)(35.0k)(54.2k)(41.3k)(12.9k)(136.1k)(303.8k)(101.5k)(109.4k)(59.1k)41.8k

Cash From Operating Activities

(1.7m)(1.8m)(194.0k)(47.8k)(227.1k)129.0k345.7k333.0k222.4k127.5k956.6k207.9k(8.9k)515.9k185.9k290.1k512.3k195.2k77.2k278.3k(434.3k)(1.5m)(3.1m)(519.4k)(912.7k)(1.0m)(67.5k)

Purchases of PP&E

130.8k203.4k(67.0k)(158.0k)162.7k(129.2k)(126.5k)(131.5k)(118.5k)(128.7k)(38.0k)(14.5k)(17.9k)(22.9k)

Cash From Investing Activities

(660.0k)(775.7k)(160.4k)(251.5k)(16.7k)(129.2k)(126.5k)(131.5k)(118.5k)(128.7k)(113.0k)(14.5k)(7.9k)11.0k69.5k84.5k93.8k29.6k55.0k55.0k55.0k

Short-term Borrowings

(16.3k)(1.1m)1.1m(750.0k)(1.2m)(275.0k)(300.0k)(300.0k)(300.0k)

Cash From Financing Activities

2.2m2.5m458.7k435.8k433.4k(300.0k)(26.0k)(501.0k)(275.0k)(300.0k)(300.0k)(300.0k)

Net Change in Cash

(141.2k)(111.7k)104.3k136.6k187.6k(190.0)219.2k201.5k4.7k(6.9k)(9.3k)(106.7k)(42.7k)25.9k255.4k374.5k331.1k(104.8k)(193.1k)33.3k125.8k12.2m11.0m(519.4k)(912.7k)(1.0m)(67.5k)

Interest Paid

2.1k

Income Taxes Paid

(353.0k)(641.0k)(662.8k)

Cord Blood America Ratios

USDQ2, 2011

Debt/Equity

-7.1 x

Debt/Assets

0.4 x

Financial Leverage

-17.1 x
View Cord Blood America profile

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Learn more